World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
109
Citations
47343
World Ranking
516
National Ranking
26

Medicine

D-Index
109
Citations
47752
World Ranking
5742
National Ranking
319

Overview

Margitta Worm is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily focuses on the field of Medicine, with a significant concentration in Immunology and Allergy, Dermatology, Physiology, Rheumatology, and Pharmacology.

Their work extensively covers various topics, including:

  • Food Allergy and Anaphylaxis Research
  • Allergic Rhinitis and Sensitization
  • Dermatology and Skin Diseases
  • Contact Dermatitis and Allergies
  • Asthma and respiratory diseases
  • Urticaria and Related Conditions
  • Drug-Induced Adverse Reactions

Margitta Worm has published research articles in several notable venues, frequently contributing to:

  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Allergy
  • Allergo Journal
  • Allergologie
  • Allergologie select

Among the recent papers associated with their research are:

  • World Allergy Organization Anaphylaxis Guidance 2020, 2020, World Allergy Organization Journal
  • Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2), 2020, British Journal of Dermatology
  • EAACI guidelines: Anaphylaxis (2021 update), 2021, Allergy
  • The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach, 2021, The Journal of Allergy and Clinical Immunology In Practice
  • Frequency of food allergy in Europe: An updated systematic review and meta-analysis, 2022, Allergy

The scientist collaborates frequently with other researchers, notably:

  • Regina Treudler
  • Sabine Dölle
  • Ludger Klimek
  • Kirsten Beyer
  • Oliver Pfaar

Best Publications

  • Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    Eric L. Simpson;Thomas Bieber;Emma Guttman-Yassky;Lisa A. Beck

  • EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy

    A. Muraro;T. Werfel;K. Hoffmann-Sommergruber;G. Roberts;G. Roberts;G. Roberts

  • Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology

    A. Muraro;G. Roberts;M. Worm;M. B. Bilo

  • World Allergy Organization Anaphylaxis Guidance 2020

    Victoria Cardona;Ignacio J Ansotegui;Motohiro Ebisawa;Yehia El-Gamal

  • EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

    G. Roberts;G. Roberts;G. Roberts;O. Pfaar;C. A. Akdis;I. J. Ansotegui

  • S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update

    Enno Schmidt;Michael Sticherling;Miklós Sárdy;Rüdiger Eming

  • Impact of gender on asthma in childhood and adolescence: a GA2LEN review.

    Almqvist C;Worm M;Leynaert B

  • Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

    Diamant Thaçi;Eric L Simpson;Lisa A Beck;Thomas Bieber

  • Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.

    Alain Didier;Hans-Jörgen Malling;Margitta Worm;Friedrich Horak

  • Anaphylaxis in children and adolescents: The European Anaphylaxis Registry

    Linus B. Grabenhenrich;Sabine Dölle;Anne Moneret-Vautrin;Alice Köhli

  • 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.

    F. Estelle R. Simons;Motohiro Ebisawa;Mario Sanchez-Borges;Bernard Y. Thong

  • Direct access to CD4 + T cells specific for defined antigens according to CD154 expression

    Marco Frentsch;Olga Arbach;Dennis Kirchhoff;Beate Moewes

  • IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.

    D Schadendorf;A Möller;B Algermissen;M Worm

  • Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    A. Wollenberg;A. Blauvelt;E. Guttman‐Yassky;M. Worm

  • International consensus on (ICON) anaphylaxis

    F. Estelle R. Simons;Ledit R.F. Ardusso;M Beatrice Bilò;Victoria Cardona

  • Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    Jérôme Avouac;J. Fransen;U. A. Walker;V. Riccieri

  • Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march.

    Ingo Marenholz;Renate Nickel;Franz Rüschendorf;Florian Schulz

  • EAACI guideline: Anaphylaxis (2021 update).

    Antonella Muraro;Margitta Worm;Cherry Alviani;Victoria Cardona

  • The epidemiology of anaphylaxis in Europe: a systematic review.

    S S Panesar;S Javad;D de Silva;B I Nwaru

  • Prevalence of adverse reactions to food in Germany - a population study.

    T. Zuberbier;G. Edenharter;M. Worm;I. Ehlers

  • Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans.

    Petra Bacher;Thordis Hohnstein;Eva Beerbaum;Marie Röcker

  • Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

    Oliver Pfaar;Claus Bachert;Albrecht Bufe;Roland Buhl

Frequent Co-Authors

Thomas Werfel
Thomas Werfel Hannover Medical School
Torsten Zuberbier
Torsten Zuberbier Charité - University Medicine Berlin
Ludger Klimek
Ludger Klimek Ghent University
Thomas Fuchs
Thomas Fuchs University of Göttingen
Kirsten Beyer
Kirsten Beyer Charité - University Medicine Berlin
Knut Brockow
Knut Brockow Technical University of Munich
Tilo Biedermann
Tilo Biedermann Technical University of Munich
Johannes Ring
Johannes Ring Technical University of Munich
Hans F. Merk
Hans F. Merk RWTH Aachen University
Graham Roberts
Graham Roberts University of Southampton

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers, often requiring complementary nursing qualifications. For those without a nursing background, several online programs are designed to facilitate career transitions. Programs like online BSN programs for non nurses offer flexible pathways to earn a Bachelor of Science in Nursing, making it easier to enter the medical field alongside immunology expertise.

For students aiming for a faster route, the easiest ABSN program to get into provides accelerated curricula designed to quickly prepare individuals for nursing roles, which often overlap with immunological practices in clinical settings.

Licensed Practical Nurse (LPN) careers also offer a practical entry point, with many institutions offering accredited LPN programs easy to get into. These programs are ideal for gaining hands-on healthcare experience that complements immunology studies.

Advancing further into specialized care, pursuing the easiest NP program can lead to roles that blend nursing expertise with immunological knowledge, particularly in clinical research and patient care for immune-related conditions.

Best Scientists Citing Margitta Worm

Trending Scientists